Enoxaparin and Bleeding Complications: A Review in Patients with and without Renal Insufficiency
Open Access
- 1 July 2000
- journal article
- review article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 20 (7), 771-775
- https://doi.org/10.1592/phco.20.9.771.35210
Abstract
Study Objective. To compare the frequency of bleeding complications from enoxaparin in patients with normal renal function versus patients with renal insufficiency. Design. Retrospective chart review. Setting. University‐based tertiary care center. Patients. One hundred six patients who received two or more doses of enoxaparin. Measurements and Main Results. Total bleeding complications occurred in 22% of patients with normal renal function and 51% with renal insufficiency (p<0.01). Major bleeds were also significantly different, 2% and 30%, respectively (p<0.001). No patients with normal renal function were given fresh‐frozen plasma or packed red blood cells, whereas in those with renal insufficiency, 13% and 32%, respectively, received these products (p<0.01). Conclusion. Enoxaparin may have resulted in increased bleeding complications and use of blood products in patients with renal insufficiency. Prospective studies need to be conducted to define the drug's role and dosage adjustments in these patients. (Pharmacotherapy 2000; 20(7):771–775)Keywords
This publication has 10 references indexed in Scilit:
- Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation, 1999
- Inappropriate Use of Enoxaparin in the Treatment of Deep-Vein ThrombosisThe New England Journal of Medicine, 1999
- Heparin and Low-Molecular-Weight HeparinSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1998
- Low-molecular-weight heparins: pharmacologic profile and product differentiationThe American Journal of Cardiology, 1998
- Monitoring of low-molecular-weight heparins in cardiovascular diseaseThe American Journal of Cardiology, 1998
- Optimal weight base for a weight-based heparin dosing protocol.American Journal of Health-System Pharmacy, 1998
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseThe New England Journal of Medicine, 1997
- A Comparison of Low-Dose Heparin with Low-Molecular-Weight Heparin as Prophylaxis against Venous Thromboembolism after Major TraumaThe New England Journal of Medicine, 1996
- Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis against Venous Thromboembolism after Total Hip ReplacementThe New England Journal of Medicine, 1996
- Delayed elimination of enoxaparine in patients with chronic renal insufficiencyThrombosis Research, 1991